<p>達科塔財富管理在最近向證券交易委員會（SEC）披露的文件中表示，在第三季度將其在直覺外科公司（NASDAQ:ISRG - 免費報告）的股份減少了 63.9%。該基金在季度內出售了 8,291 股後，持有 4,692 股該醫療設備提供商的股票。截至其最近向證券交易委員會（SEC）提交的文件，達科塔財富管理在直覺外科的持股價值為 2,098,000 美元。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
<p>其他機構投資者最近也對該公司的持倉進行了調整。挪威銀行在第二季度購買了價值 25,692,600,000 美元的直覺外科新股份。樂天投資管理公司在第三季度購買了價值約 388,436,000 美元的直覺外科新股份。先鋒集團在第二季度將其在直覺外科的股份增加了 2.1%。先鋒集團目前持有 33,335,833 股該醫療設備提供商的股票，價值為 18,115,025,000 美元，此前在上個季度又購買了 670,302 股。Jennison Associates LLC 在第二季度將其在直覺外科的股份增加了 20.4%。Jennison Associates LLC 目前持有 3,122,390 股該醫療設備提供商的股票，價值為 1,696,738,000 美元，此前在上個季度又購買了 528,359 股。最後，加拿大養老金計劃投資委員會在第二季度將其在直覺外科的股份增加了 27.1%。加拿大養老金計劃投資委員會目前持有 1,089,293 股該醫療設備提供商的股票，價值為 591,933,000 美元，此前在上個季度又購買了 231,980 股。機構投資者持有該公司 83.64% 的股份。</p>
<h2>Intuitive Surgical 股票上漲 2.5%</h2>
<p>直覺外科的股票週四開盤價為 506.17 美元。該公司的 50 日簡單移動平均線為 532.31 美元，200 日簡單移動平均線為 511.29 美元。直覺外科公司 12 個月低點為 425.00 美元，12 個月高點為 603.88 美元。該公司的市值為 1797.6 億美元，市盈率為 64.15，市盈率增長比率為 3.83，貝塔值為 1.65。</p>
<ul>
<li>Intuitive Surgical 剛剛證明增長引擎仍在運轉</li>
</ul>
<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近一次發佈財報是在 1 月 22 日，醫療設備提供商報告該季度每股收益為 2.53 美元，超出分析師一致預期的 2.27 美元，超出幅度為 0.26 美元。該季度的收入為 28.7 億美元，而分析師預期為 27.2 億美元。直覺外科的淨利潤率為 28.38%，股本回報率為 15.06%。直覺外科該季度的收入同比增長 18.8%。在去年同期，該公司每股收益為 2.21 美元。整體來看，賣方分析師預計直覺外科公司在當前財年將發佈每股收益 6.43 美元。</p>
<h2>華爾街分析師觀點</h2>
<p>多家券商對 ISRG 發表了評論。雷蒙德·詹姆斯金融公司將直覺外科的股票目標價從 603.00 美元上調至 615.00 美元，並在 1 月 23 日的研究報告中給予該公司 “跑贏大盤” 的評級。韋斯評級在 12 月 29 日的研究報告中重申了對直覺外科的 “持有（c+）” 評級。阿根斯將直覺外科的目標價從 630.00 美元下調至 560.00 美元，並在 2 月 4 日的研究報告中對該股票給予 “買入” 評級。花旗集團在 1 月 23 日的研究報告中重申了 “中性” 評級，並將直覺外科的目標價設定為 590.00 美元（低於 635.00 美元）。最後，羅伯特·W·貝爾德在 1 月 23 日的報告中將直覺外科的目標價從 655.00 美元下調至 645.00 美元，並對該股票給予 “跑贏大盤” 評級。兩位研究分析師對該股票給予 “強烈買入” 評級，十五位給予 “買入” 評級，七位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價為 615.86 美元。</p>
<ul>
<li>2 只醫療股可能因財報而獲得大幅提振</li>
</ul>
<p><strong>查看我們對直覺外科的最新分析</strong></p>
<h2>內部人士下注</h2>
<p>在相關消息中，SVP Mark Brosius 在 12 月 15 日的交易中出售了 464 股公司的股票，交易平均價格為 548.49 美元，總交易額為 254,499.36 美元。交易完成後，該高級副總裁在公司持有 131 股，價值為 71,852.19 美元。這代表其持股減少了 77.98%。該出售在與證券交易委員會的法律文件中披露，文件可通過此鏈接獲取。此外，副總裁 Fredrik Widman 在 2 月 11 日的交易中出售了 133 股直覺外科的股票，平均價格為 494.96 美元，總交易額為 65,829.68 美元。交易完成後，該副總裁在公司持有 660 股，價值約為 326,673.60 美元。該交易代表其持股減少了 16.77%。該出售的披露在 SEC 文件中可獲得。在過去 90 天內，內部人士共出售了價值 30,785,441 美元的 56,189 股公司股票。0.70% 的股票由公司內部人士持有。</p>
<h2>直覺外科公司簡介</h2>
<p>（免費報告）</p>
<p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
<p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
<h2>另請參見</h2>
<ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>揭示：白宮背後發生的大事</li>
<li>警報：在明天市場開盤前拋售這五隻股票！</li>
<li>埃隆·馬斯克：這可能將 100 美元變成 100,000 美元</li>
<li>閲讀此文，否則將永遠後悔</li>
<li>下一個商品危機（比石油還大？）</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

標普健康醫療設備 ETF - SPDR

美國醫藥設備 ETF - iShares

UTRS

直覺外科

ASXC

ISUL

<p>Dakota Wealth Management 在第三季度減少了對 Intuitive Surgical, Inc. (NASDAQ: ISRG) 的持股比例，降幅為 63.9%，目前持有 4,692 股，市值為 210 萬美元。其他機構投資者，包括挪威銀行和先鋒集團，也調整了他們的持倉。Intuitive Surgical 的股票上漲了 2.5%，開盤價為 506.17 美元，市值為 1797.6 億美元。該公司報告每股收益為 2.53 美元，超出預期，營收同比增長 18.8%。分析師維持 “適度買入” 的共識評級，平均目標價為 615.86 美元</p>

<p>Dakota Wealth Management cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 63.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,692 shares of the medical equipment provider's stock after selling 8,291 shares during the quarter. Dakota Wealth Management's holdings in Intuitive Surgical were worth $2,098,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>達科塔財富管理在最近向證券交易委員會（SEC）披露的文件中表示，在第三季度將其在直覺外科公司（NASDAQ:ISRG - 免費報告）的股份減少了 63.9%。該基金在季度內出售了 8,291 股後，持有 4,692 股該醫療設備提供商的股票。截至其最近向證券交易委員會（SEC）提交的文件，達科塔財富管理在直覺外科的持股價值為 2,098,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技術——3 只適合成長型投資者的醫療股</li>
</ul>
</div><p>Other institutional investors have also recently made changes to their positions in the company. Norges Bank purchased a new position in Intuitive Surgical in the second quarter worth $2,569,260,000. Rakuten Investment Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth about $388,436,000. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock valued at $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. Jennison Associates LLC increased its position in shares of Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider's stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the last quarter. Finally, Canada Pension Plan Investment Board lifted its position in Intuitive Surgical by 27.1% in the 2nd quarter. Canada Pension Plan Investment Board now owns 1,089,293 shares of the medical equipment provider's stock worth $591,933,000 after buying an additional 231,980 shares during the last quarter. Institutional investors own 83.64% of the company's stock.</p>
<div class="lb-trans"><p>其他機構投資者最近也對該公司的持倉進行了調整。挪威銀行在第二季度購買了價值 25,692,600,000 美元的直覺外科新股份。樂天投資管理公司在第三季度購買了價值約 388,436,000 美元的直覺外科新股份。先鋒集團在第二季度將其在直覺外科的股份增加了 2.1%。先鋒集團目前持有 33,335,833 股該醫療設備提供商的股票，價值為 18,115,025,000 美元，此前在上個季度又購買了 670,302 股。Jennison Associates LLC 在第二季度將其在直覺外科的股份增加了 20.4%。Jennison Associates LLC 目前持有 3,122,390 股該醫療設備提供商的股票，價值為 1,696,738,000 美元，此前在上個季度又購買了 528,359 股。最後，加拿大養老金計劃投資委員會在第二季度將其在直覺外科的股份增加了 27.1%。加拿大養老金計劃投資委員會目前持有 1,089,293 股該醫療設備提供商的股票，價值為 591,933,000 美元，此前在上個季度又購買了 231,980 股。機構投資者持有該公司 83.64% 的股份。</p>
</div><h2>Intuitive Surgical Stock Up 2.5%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股票上漲 2.5%</h2>
</div><p>Shares of Intuitive Surgical stock opened at $506.17 on Thursday. The company's fifty day simple moving average is $532.31 and its two-hundred day simple moving average is $511.29. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88. The firm has a market cap of $179.76 billion, a PE ratio of 64.15, a price-to-earnings-growth ratio of 3.83 and a beta of 1.65.</p>
<div class="lb-trans"><p>直覺外科的股票週四開盤價為 506.17 美元。該公司的 50 日簡單移動平均線為 532.31 美元，200 日簡單移動平均線為 511.29 美元。直覺外科公司 12 個月低點為 425.00 美元，12 個月高點為 603.88 美元。該公司的市值為 1797.6 億美元，市盈率為 64.15，市盈率增長比率為 3.83，貝塔值為 1.65。</p>
</div><ul>
<li>Intuitive Surgical Just Proved the Growth Engine Still Runs</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 剛剛證明增長引擎仍在運轉</li>
</ul>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts' consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical's revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.21 earnings per share. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近一次發佈財報是在 1 月 22 日，醫療設備提供商報告該季度每股收益為 2.53 美元，超出分析師一致預期的 2.27 美元，超出幅度為 0.26 美元。該季度的收入為 28.7 億美元，而分析師預期為 27.2 億美元。直覺外科的淨利潤率為 28.38%，股本回報率為 15.06%。直覺外科該季度的收入同比增長 18.8%。在去年同期，該公司每股收益為 2.21 美元。整體來看，賣方分析師預計直覺外科公司在當前財年將發佈每股收益 6.43 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>A number of brokerages have commented on ISRG. Raymond James Financial increased their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, January 23rd. Weiss Ratings reaffirmed a &#34;hold (c+)&#34; rating on shares of Intuitive Surgical in a research note on Monday, December 29th. Argus decreased their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, February 4th. Citigroup restated a &#34;neutral&#34; rating and set a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an &#34;outperform&#34; rating on the stock in a report on Friday, January 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $615.86.</p>
<div class="lb-trans"><p>多家券商對 ISRG 發表了評論。雷蒙德·詹姆斯金融公司將直覺外科的股票目標價從 603.00 美元上調至 615.00 美元，並在 1 月 23 日的研究報告中給予該公司 “跑贏大盤” 的評級。韋斯評級在 12 月 29 日的研究報告中重申了對直覺外科的 “持有（c+）” 評級。阿根斯將直覺外科的目標價從 630.00 美元下調至 560.00 美元，並在 2 月 4 日的研究報告中對該股票給予 “買入” 評級。花旗集團在 1 月 23 日的研究報告中重申了 “中性” 評級，並將直覺外科的目標價設定為 590.00 美元（低於 635.00 美元）。最後，羅伯特·W·貝爾德在 1 月 23 日的報告中將直覺外科的目標價從 655.00 美元下調至 645.00 美元，並對該股票給予 “跑贏大盤” 評級。兩位研究分析師對該股票給予 “強烈買入” 評級，十五位給予 “買入” 評級，七位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，平均目標價為 615.86 美元。</p>
</div><ul>
<li>2 Healthcare Names That Could Get a Big Boost From Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只醫療股可能因財報而獲得大幅提振</li>
</ul>
</div><p><strong>View Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們對直覺外科的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In related news, SVP Mark Brosius sold 464 shares of the company's stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares in the company, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through this hyperlink. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 56,189 shares of company stock valued at $30,785,441 in the last 90 days. 0.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，SVP Mark Brosius 在 12 月 15 日的交易中出售了 464 股公司的股票，交易平均價格為 548.49 美元，總交易額為 254,499.36 美元。交易完成後，該高級副總裁在公司持有 131 股，價值為 71,852.19 美元。這代表其持股減少了 77.98%。該出售在與證券交易委員會的法律文件中披露，文件可通過此鏈接獲取。此外，副總裁 Fredrik Widman 在 2 月 11 日的交易中出售了 133 股直覺外科的股票，平均價格為 494.96 美元，總交易額為 65,829.68 美元。交易完成後，該副總裁在公司持有 660 股，價值約為 326,673.60 美元。該交易代表其持股減少了 16.77%。該出售的披露在 SEC 文件中可獲得。在過去 90 天內，內部人士共出售了價值 30,785,441 美元的 56,189 股公司股票。0.70% 的股票由公司內部人士持有。</p>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>直覺外科公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直覺外科成立於 1995 年，總部位於加利福尼亞州的陽光谷，是一家專注於設計、製造和服務機器人輔助手術系統的醫療科技公司。該公司以其達芬奇手術系統而聞名，該系統通過將外科醫生的手部動作轉化為患者體內小型儀器的更精細、縮放的運動，從而實現微創手術。直覺外科的業務主要集中在向醫院和手術中心提供系統、儀器及相關技術，旨在提高手術室內的精確度、可視化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了核心手術平台外，直覺外科還銷售一系列可重複使用和一次性使用的儀器、配件和專有軟件，併為客户提供培訓、服務和臨牀支持。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另請參見</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>REVEALED: Something Big Happening Behind White House Doors</li>
<li>ALERT: Drop these 5 stocks before the market opens tomorrow!</li>
<li>Elon Musk: This Could Turn $100 into $100,000</li>
<li>Read this or regret it forever</li>
<li>The Next Commodity Crunch (bigger than oil?)</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過直覺外科</li>
<li>揭示：白宮背後發生的大事</li>
<li>警報：在明天市場開盤前拋售這五隻股票！</li>
<li>埃隆·馬斯克：這可能將 100 美元變成 100,000 美元</li>
<li>閲讀此文，否則將永遠後悔</li>
<li>下一個商品危機（比石油還大？）</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Dakota Wealth Management Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Market Beat

Minerva Surgical

Asensus Surgical

GraniteShares 2x Long ISRG Daily ETF

Dakota Wealth Management 減少了其在直覺外科公司（Intuitive Surgical, Inc. $ISRG）的股票持倉